首页 > 最新文献

European Journal of Oncology Nursing最新文献

英文 中文
Implementation of an eHealth-facilitated Integrated Care Model in Allogeneic Stem Cell Transplantation: The SMILe-ICM Project Belgium Context Analysis 在同种异体干细胞移植中实施电子健康促进的综合护理模式:SMILe-ICM项目比利时背景分析。
IF 2.7 3区 医学 Q1 NURSING Pub Date : 2025-11-04 DOI: 10.1016/j.ejon.2025.103033
Kristina Arnahoutova , Kathy Goris , Sabina De Geest , Juliane Mielke , Marielle Beckers , Alexandra Teynor , Lynn Leppla , Sabine Valenta , Hélène Schoemans

Purpose

Allogeneic hematopoietic stem cell transplantation (AlloHSCT) survivors have complex needs and can benefit from eHealth-facilitated integrated care models (ICM), such as the SMILe-ICM (SteM cell transplantation faciLitated by eHealth) which combines eHealth monitoring and support from an advanced practice nurse (APN). Originally developed in a Swiss/German context, it showed promising outcomes regarding mortality, rehospitalization and cost-effectiveness. Implementing the SMILe-ICM into a new setting with an existing electronic patient health record and APN support requires adaptations and selection of appropriate implementation strategies to fit the local practice. We aimed to perform a context analysis to identify barriers and facilitators to implementation and inform the effective transition of the SMILe-ICM to a different setting.

Methods

We performed a context analysis using the Basel Approach for coNtextual ANAlysis (BANANA). Based on implementation science principles, we took a mixed-methods multi-stakeholder approach to understand our local practice patterns, stakeholder expectations and needs regarding eHealth-based and nurse-led integrated post-alloHSCT care.

Results

The majority of alloHSCT patients were open to eHealth technologies and remote data-collection but patients struggled with issues related to shared-decision making, coping with daily life issues, self-management and health literacy. Healthcare providers emphasized the importance of providing appropriate training to both patients and healthcare staff regarding the SMILe-ICM, leveraging existing eHealth infrastructure, and ensuring cost-effective, sustainable implementation. The supplemental burden of eHealth data for both HCPs and patients was a key concern.

Conclusion

Our rigorous context-based approach proposes a blueprint highlighting key context insights to facilitate the implementation of eHealth ICMs in alloHSCT care.
目的:同种异体造血干细胞移植(AlloHSCT)幸存者有复杂的需求,可以从电子健康促进的综合护理模式(ICM)中受益,例如SMILe-ICM(电子健康促进的干细胞移植),它结合了电子健康监测和高级实习护士(APN)的支持。它最初是在瑞士/德国的背景下开发的,在死亡率、再住院率和成本效益方面显示出有希望的结果。在具有现有电子患者健康记录和APN支持的新环境中实施SMILe-ICM需要调整和选择适当的实施策略,以适应当地的实践。我们的目的是进行上下文分析,以确定实施的障碍和促进因素,并告知SMILe-ICM向不同环境的有效过渡。方法:我们使用巴塞尔上下文分析方法(BANANA)进行了上下文分析。基于实施科学的原则,我们采用了混合方法的多利益相关者方法来了解我们当地的实践模式、利益相关者对基于电子健康和护士主导的同种异体造血干细胞移植后综合护理的期望和需求。结果:大多数同种异体造血干细胞移植患者对电子健康技术和远程数据收集持开放态度,但患者在共同决策、应对日常生活问题、自我管理和健康素养方面存在困难。医疗保健提供者强调了向患者和医疗保健人员提供有关SMILe-ICM的适当培训、利用现有的电子医疗基础设施以及确保具有成本效益和可持续实施的重要性。对医务人员和患者来说,电子卫生数据的补充负担是一个关键问题。结论:我们严格的基于情境的方法提出了一个蓝图,突出了关键情境的见解,以促进在同种异体造血干细胞治疗中实施电子健康icm。
{"title":"Implementation of an eHealth-facilitated Integrated Care Model in Allogeneic Stem Cell Transplantation: The SMILe-ICM Project Belgium Context Analysis","authors":"Kristina Arnahoutova ,&nbsp;Kathy Goris ,&nbsp;Sabina De Geest ,&nbsp;Juliane Mielke ,&nbsp;Marielle Beckers ,&nbsp;Alexandra Teynor ,&nbsp;Lynn Leppla ,&nbsp;Sabine Valenta ,&nbsp;Hélène Schoemans","doi":"10.1016/j.ejon.2025.103033","DOIUrl":"10.1016/j.ejon.2025.103033","url":null,"abstract":"<div><h3>Purpose</h3><div>Allogeneic hematopoietic stem cell transplantation (AlloHSCT) survivors have complex needs and can benefit from eHealth-facilitated integrated care models (ICM), such as the SMILe-ICM (<strong><u>S</u></strong>te<strong><u>M</u></strong> cell transplantation faci<strong><u>L</u></strong>itated by <strong><u>e</u></strong>Health) which combines eHealth monitoring and support from an advanced practice nurse (APN). Originally developed in a Swiss/German context, it showed promising outcomes regarding mortality, rehospitalization and cost-effectiveness. Implementing the SMILe-ICM into a new setting with an existing electronic patient health record and APN support requires adaptations and selection of appropriate implementation strategies to fit the local practice. We aimed to perform a context analysis to identify barriers and facilitators to implementation and inform the effective transition of the SMILe-ICM to a different setting.</div></div><div><h3>Methods</h3><div>We performed a context analysis using the Basel Approach for coNtextual ANAlysis (BANANA). Based on implementation science principles, we took a mixed-methods multi-stakeholder approach to understand our local practice patterns, stakeholder expectations and needs regarding eHealth-based and nurse-led integrated post-alloHSCT care.</div></div><div><h3>Results</h3><div>The majority of alloHSCT patients were open to eHealth technologies and remote data-collection but patients struggled with issues related to shared-decision making, coping with daily life issues, self-management and health literacy. Healthcare providers emphasized the importance of providing appropriate training to both patients and healthcare staff regarding the SMILe-ICM, leveraging existing eHealth infrastructure, and ensuring cost-effective, sustainable implementation. The supplemental burden of eHealth data for both HCPs and patients was a key concern.</div></div><div><h3>Conclusion</h3><div>Our rigorous context-based approach proposes a blueprint highlighting key context insights to facilitate the implementation of eHealth ICMs in alloHSCT care.</div></div>","PeriodicalId":51048,"journal":{"name":"European Journal of Oncology Nursing","volume":"79 ","pages":"Article 103033"},"PeriodicalIF":2.7,"publicationDate":"2025-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145524889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Strategies for improving healthcare provider communication with cancer patients about fertility preservation: a scoping review 改善医疗保健提供者与癌症患者关于保留生育能力的沟通策略:范围综述
IF 2.7 3区 医学 Q1 NURSING Pub Date : 2025-11-03 DOI: 10.1016/j.ejon.2025.103034
Ying-Xiang Chen , You Zhou , Fu-Ying Ye, Xiao-Lan Zhang, Min Xu

Purpose

This study seeks to consolidate practices that improve healthcare practitioners' communication about fertility preservation with cancer patients. Through a scoping review, we seek to inform the development and implementation of effective strategies moving forward.

Methods

Nine databases were searched, including PubMed, CINAHL, Web of Science, ProQuest, Cochrane Library, Embase, China National Knowledge Infrastructure, Wanfang Data, and VIP Database. The most recent search occurred on September 13, 2024. The inclusion criteria were established based on the PCC (Participants, Concept, Context) framework. The protocol for this scope review was unregistered.

Results

A total of 22 studies were included in this study, using 19 strategies to improve fertility preservation communication. These strategies were categorized into three main areas: educational tools, communication tools, and educational training. Educational tools comprised clinician instruction manuals, patient and family brochures, fertility risk assessment tools, fertility preservation option grids, educational videos, international guideline lists, checklists, and referral checklists. Communication tools included discussion scripts, stress eggs, automated reminder and recording systems, and the Frank narrative method. Educational training methods encompassed presentations, case studies, role play, video instruction, feedback and coaching, professional lectures, educational group meetings, and hands-on exercises.

Conclusion

Strategies for communicating fertility preservation enhanced healthcare practitioners' knowledge, communication abilities, satisfaction, and self-efficacy, while also improving the quality and frequency of communication. The results of this study hold considerable significance for healthcare practitioners in delivering oncologic reproductive support, enhancing patient quality of life and the quality of fertility preservation choices.
目的本研究旨在加强医疗保健从业者与癌症患者关于保留生育能力的沟通。通过范围审查,我们力求为今后有效战略的制定和实施提供信息。方法检索PubMed、CINAHL、Web of Science、ProQuest、Cochrane Library、Embase、中国知识基础设施、万方数据、VIP数据库等9个数据库。最近一次搜索发生在2024年9月13日。纳入标准是基于PCC(参与者,概念,背景)框架建立的。本次范围评审的方案未注册。结果本研究共纳入22项研究,采用19种策略改善生育保留沟通。这些策略被分为三个主要领域:教育工具、交流工具和教育培训。教育工具包括临床医生指导手册、患者和家庭手册、生育风险评估工具、生育保留选项网格、教育视频、国际指南清单、清单和转诊清单。沟通工具包括讨论脚本、压力蛋、自动提醒和记录系统,以及弗兰克叙事法。教育培训方法包括演讲、案例研究、角色扮演、视频指导、反馈和指导、专业讲座、教育小组会议和实践练习。结论生育保留沟通策略提高了保健医生的知识水平、沟通能力、满意度和自我效能感,同时提高了沟通质量和频率。本研究的结果对医疗保健从业者提供肿瘤生殖支持,提高患者的生活质量和生育保留选择的质量具有相当大的意义。
{"title":"Strategies for improving healthcare provider communication with cancer patients about fertility preservation: a scoping review","authors":"Ying-Xiang Chen ,&nbsp;You Zhou ,&nbsp;Fu-Ying Ye,&nbsp;Xiao-Lan Zhang,&nbsp;Min Xu","doi":"10.1016/j.ejon.2025.103034","DOIUrl":"10.1016/j.ejon.2025.103034","url":null,"abstract":"<div><h3>Purpose</h3><div>This study seeks to consolidate practices that improve healthcare practitioners' communication about fertility preservation with cancer patients. Through a scoping review, we seek to inform the development and implementation of effective strategies moving forward.</div></div><div><h3>Methods</h3><div>Nine databases were searched, including PubMed, CINAHL, Web of Science, ProQuest, Cochrane Library, Embase, China National Knowledge Infrastructure, Wanfang Data, and VIP Database. The most recent search occurred on September 13, 2024. The inclusion criteria were established based on the PCC (Participants, Concept, Context) framework. The protocol for this scope review was unregistered.</div></div><div><h3>Results</h3><div>A total of 22 studies were included in this study, using 19 strategies to improve fertility preservation communication. These strategies were categorized into three main areas: educational tools, communication tools, and educational training. Educational tools comprised clinician instruction manuals, patient and family brochures, fertility risk assessment tools, fertility preservation option grids, educational videos, international guideline lists, checklists, and referral checklists. Communication tools included discussion scripts, stress eggs, automated reminder and recording systems, and the Frank narrative method. Educational training methods encompassed presentations, case studies, role play, video instruction, feedback and coaching, professional lectures, educational group meetings, and hands-on exercises.</div></div><div><h3>Conclusion</h3><div>Strategies for communicating fertility preservation enhanced healthcare practitioners' knowledge, communication abilities, satisfaction, and self-efficacy, while also improving the quality and frequency of communication. The results of this study hold considerable significance for healthcare practitioners in delivering oncologic reproductive support, enhancing patient quality of life and the quality of fertility preservation choices.</div></div>","PeriodicalId":51048,"journal":{"name":"European Journal of Oncology Nursing","volume":"79 ","pages":"Article 103034"},"PeriodicalIF":2.7,"publicationDate":"2025-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145528822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identifying gender-specific treatment targets for depression in cancer survivors: Evidence from NHANES 确定癌症幸存者抑郁症的性别特异性治疗目标:来自NHANES的证据
IF 2.7 3区 医学 Q1 NURSING Pub Date : 2025-11-02 DOI: 10.1016/j.ejon.2025.103030
Yiguo Deng , Furong Chen , Ying Xiong , Siyu Li , Qihan Zhang , M. Tish Knobf , Jiaying Li , Zengjie Ye

Purpose

Depression is a prevalent and heterogeneous symptom among cancer survivors, yet gender-specific differences in symptom patterns remain underexplored. This study aims to characterize gender-specific depressive-symptom networks in cancer survivors and identify optimal intervention targets via computer-simulated interventions.

Methods

In this cross-sectional study of 2141 cancer survivors from seven National Health and Nutrition Examination Survey (NHANES) cycles, we compared Patient Health Questionnaire-9 (PHQ-9) scores by gender. We used Gaussian graphical models to identify core symptoms, applied Bayesian network analysis to map symptom activation pathways, and conducted computer-simulated interventions to pinpoint gender-specific treatment targets.

Results

Overall, the average PHQ-9 scores were relatively low, suggesting very mild reported depressive symptoms. In men's networks, three central nodes, specifically “depressed mood”, “anhedonia”, and “psychomotor changes” emerged. “Worthlessness” was identified as the primary driver of “suicidal ideation”, with “worthlessness” and “fatigue” as the potential intervention targets. In women's networks, “depressed mood” served as the only core symptom driving “concentration difficulties”, with “depressed mood” and “psychomotor changes” as the potential intervention targets.

Conclusion

Distinct gender-specific differences in core depressive emerged in cancer survivors’ symptom networks. These findings provide direction for targeted psychosocial interventions in oncology care.
目的:抑郁症是癌症幸存者中普遍存在的异质性症状,但症状模式的性别差异仍未得到充分研究。本研究旨在描述癌症幸存者中性别特异性抑郁症状网络,并通过计算机模拟干预确定最佳干预目标。方法对来自7个国家健康与营养调查(NHANES)周期的2141名癌症幸存者进行横断面研究,按性别比较患者健康问卷-9 (PHQ-9)得分。我们使用高斯图形模型来识别核心症状,应用贝叶斯网络分析来绘制症状激活途径,并进行计算机模拟干预以确定针对性别的治疗目标。结果总体而言,平均PHQ-9得分相对较低,表明报告的抑郁症状非常轻微。在男性的神经网络中,出现了三个中心节点,特别是“抑郁情绪”、“快感缺乏”和“精神运动变化”。“无价值”被确定为“自杀意念”的主要驱动因素,“无价值”和“疲劳”是潜在的干预目标。在女性网络中,“抑郁情绪”是导致“注意力集中困难”的唯一核心症状,“抑郁情绪”和“精神运动变化”是潜在的干预目标。结论癌症幸存者的核心抑郁症状网络存在明显的性别差异。这些发现为肿瘤治疗中有针对性的社会心理干预提供了方向。
{"title":"Identifying gender-specific treatment targets for depression in cancer survivors: Evidence from NHANES","authors":"Yiguo Deng ,&nbsp;Furong Chen ,&nbsp;Ying Xiong ,&nbsp;Siyu Li ,&nbsp;Qihan Zhang ,&nbsp;M. Tish Knobf ,&nbsp;Jiaying Li ,&nbsp;Zengjie Ye","doi":"10.1016/j.ejon.2025.103030","DOIUrl":"10.1016/j.ejon.2025.103030","url":null,"abstract":"<div><h3>Purpose</h3><div>Depression is a prevalent and heterogeneous symptom among cancer survivors, yet gender-specific differences in symptom patterns remain underexplored. This study aims to characterize gender-specific depressive-symptom networks in cancer survivors and identify optimal intervention targets via computer-simulated interventions.</div></div><div><h3>Methods</h3><div>In this cross-sectional study of 2141 cancer survivors from seven National Health and Nutrition Examination Survey (NHANES) cycles, we compared Patient Health Questionnaire-9 (PHQ-9) scores by gender. We used Gaussian graphical models to identify core symptoms, applied Bayesian network analysis to map symptom activation pathways, and conducted computer-simulated interventions to pinpoint gender-specific treatment targets.</div></div><div><h3>Results</h3><div>Overall, the average PHQ-9 scores were relatively low, suggesting very mild reported depressive symptoms. In men's networks, three central nodes, specifically “depressed mood”, “anhedonia”, and “psychomotor changes” emerged. “Worthlessness” was identified as the primary driver of “suicidal ideation”, with “worthlessness” and “fatigue” as the potential intervention targets. In women's networks, “depressed mood” served as the only core symptom driving “concentration difficulties”, with “depressed mood” and “psychomotor changes” as the potential intervention targets.</div></div><div><h3>Conclusion</h3><div>Distinct gender-specific differences in core depressive emerged in cancer survivors’ symptom networks. These findings provide direction for targeted psychosocial interventions in oncology care.</div></div>","PeriodicalId":51048,"journal":{"name":"European Journal of Oncology Nursing","volume":"80 ","pages":"Article 103030"},"PeriodicalIF":2.7,"publicationDate":"2025-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145532985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Supporting women with adherence to adjuvant endocrine therapy (SWEET): feasibility study of the HT&Me intervention 支持妇女坚持辅助内分泌治疗(SWEET): HT&Me干预的可行性研究
IF 2.7 3区 医学 Q1 NURSING Pub Date : 2025-11-01 DOI: 10.1016/j.ejon.2025.103026
Lucy McGeagh , Sarah-Jane Stewart , Ruth Norris , Mary Wells , Sue Thompson , Phil Mawson , Jo Brett , Mark Turner , Jane Wolstenholme , Helen Dakin , Peter Donnelly , Henry Cain , Farah Rehman , Sally Kum , Rob Horne , Guy Taylor , Lesley Turner , Jan Rose , Linda Sharp , Eila Watson

Purpose

Women with estrogen receptor-positive breast cancer are recommended daily oral adjuvant endocrine therapy for at least 5 years, but up to 50 % discontinue early. We assessed an evidence-based, theoretically-informed, patient-centred intervention (HT&Me) to support adjuvant endocrine therapy adherence and improve quality-of-life, in terms of patient acceptability and feasibility to deliver within the UK National Health Service.

Methods

This single arm study aimed to recruit 45 women with stage I-III breast cancer within 14 weeks of first adjuvant endocrine therapy prescription. After completing baseline questionnaires, participants received the HT&Me intervention comprising: (i) a short animation; (ii) two personalised nurse/practitioner consultations (in-person or online); (iii) an interactive web-app; and (iv) regular email reminders. Participants completed follow-up questionnaires at 8 weeks. A sub-sample of participants (n = 20) and health professionals (n = 14) participated in semi-structured interviews.

Results

We recruited 51 participants. Participants varied in digital confidence at recruitment (low/moderate, 28 % (n = 14); high, 61 % (n = 31)). HT&Me was demonstrated as feasible to deliver. Overall, 69 % (n = 35) engaged with the web-app; 87 % (n = 40/46) found HT&Me helpful; and 80 % (n = 36/45) reported it motivated them to keep taking endocrine therapy. Both consultation formats were considered acceptable. Completion of outcome measures was high. Health professionals considered HT&Me addresses an important unmet need.

Conclusions

HT&Me is feasible, acceptable and helpful to women. Findings provided valuable insights for design and delivery of the full-scale randomised controlled trial assessing effectiveness now underway (ISRCTN24852890). HT&Me offers potential to improve adjuvant endocrine therapy adherence, thereby reducing recurrence risk for women with estrogen receptor positive breast cancer.

Study registration ISRCTN number

ISRCTN29401613
目的雌激素受体阳性乳腺癌患者推荐每日口服辅助内分泌治疗至少5年,但高达50%的患者早期停止治疗。我们评估了一种基于证据、理论信息、以患者为中心的干预(HT&Me),以支持辅助内分泌治疗的依从性并改善生活质量,在英国国家卫生服务体系内提供患者的可接受性和可行性。方法本单臂研究旨在招募45例首次辅助内分泌治疗处方14周内的I-III期乳腺癌患者。在完成基线问卷后,参与者接受HT&;Me干预,包括:(i)一个简短的动画;(ii)两次个人化护士/执业医师会诊(当面或网上);(iii)交互式网页应用程序;(iv)定期电子邮件提醒。参与者在8周后完成随访问卷。参与者的子样本(n = 20)和卫生专业人员(n = 14)参加了半结构化访谈。结果我们招募了51名参与者。参与者在招聘时的数字信心各不相同(低/中等,28% (n = 14);高,61% (n = 31))。HT&;Me被证明是可行的。总体而言,69% (n = 35)的用户使用了网页应用;87% (n = 40/46)的人认为HT&;Me有帮助;80% (n = 36/45)的人报告说,这促使他们继续接受内分泌治疗。两种协商形式都被认为是可以接受的。结果测量的完成率很高。结论体外受精是可行的、可接受的,对女性有一定的帮助。研究结果为目前正在进行的评估有效性的全面随机对照试验(ISRCTN24852890)的设计和交付提供了有价值的见解。HT&;Me有可能提高辅助内分泌治疗的依从性,从而降低雌激素受体阳性乳腺癌妇女的复发风险。研究注册号码:isrctn29401613
{"title":"Supporting women with adherence to adjuvant endocrine therapy (SWEET): feasibility study of the HT&Me intervention","authors":"Lucy McGeagh ,&nbsp;Sarah-Jane Stewart ,&nbsp;Ruth Norris ,&nbsp;Mary Wells ,&nbsp;Sue Thompson ,&nbsp;Phil Mawson ,&nbsp;Jo Brett ,&nbsp;Mark Turner ,&nbsp;Jane Wolstenholme ,&nbsp;Helen Dakin ,&nbsp;Peter Donnelly ,&nbsp;Henry Cain ,&nbsp;Farah Rehman ,&nbsp;Sally Kum ,&nbsp;Rob Horne ,&nbsp;Guy Taylor ,&nbsp;Lesley Turner ,&nbsp;Jan Rose ,&nbsp;Linda Sharp ,&nbsp;Eila Watson","doi":"10.1016/j.ejon.2025.103026","DOIUrl":"10.1016/j.ejon.2025.103026","url":null,"abstract":"<div><h3>Purpose</h3><div>Women with estrogen receptor-positive breast cancer are recommended daily oral adjuvant endocrine therapy for at least 5 years, but up to 50 % discontinue early. We assessed an evidence-based, theoretically-informed, patient-centred intervention (HT&amp;Me) to support adjuvant endocrine therapy adherence and improve quality-of-life, in terms of patient acceptability and feasibility to deliver within the UK National Health Service.</div></div><div><h3>Methods</h3><div>This single arm study aimed to recruit 45 women with stage I-III breast cancer within 14 weeks of first adjuvant endocrine therapy prescription. After completing baseline questionnaires, participants received the HT&amp;Me intervention comprising: (i) a short animation; (ii) two personalised nurse/practitioner consultations (in-person or online); (iii) an interactive web-app; and (iv) regular email reminders. Participants completed follow-up questionnaires at 8 weeks. A sub-sample of participants (n = 20) and health professionals (n = 14) participated in semi-structured interviews.</div></div><div><h3>Results</h3><div>We recruited 51 participants. Participants varied in digital confidence at recruitment (low/moderate, 28 % (n = 14); high, 61 % (n = 31)). HT&amp;Me was demonstrated as feasible to deliver. Overall, 69 % (n = 35) engaged with the web-app; 87 % (n = 40/46) found HT&amp;Me helpful; and 80 % (n = 36/45) reported it motivated them to keep taking endocrine therapy. Both consultation formats were considered acceptable. Completion of outcome measures was high. Health professionals considered HT&amp;Me addresses an important unmet need.</div></div><div><h3>Conclusions</h3><div>HT&amp;Me is feasible, acceptable and helpful to women. Findings provided valuable insights for design and delivery of the full-scale randomised controlled trial assessing effectiveness now underway (ISRCTN24852890). HT&amp;Me offers potential to improve adjuvant endocrine therapy adherence, thereby reducing recurrence risk for women with estrogen receptor positive breast cancer.</div></div><div><h3>Study registration ISRCTN number</h3><div>ISRCTN29401613</div></div>","PeriodicalId":51048,"journal":{"name":"European Journal of Oncology Nursing","volume":"80 ","pages":"Article 103026"},"PeriodicalIF":2.7,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145796603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of the effect of active cycle of breathing techniques on respiratory distress symptom cluster in patients with lung cancer: A randomised controlled trial 主动循环呼吸技术对肺癌患者呼吸窘迫症状群的影响:一项随机对照试验
IF 2.7 3区 医学 Q1 NURSING Pub Date : 2025-10-31 DOI: 10.1016/j.ejon.2025.103029
Doga Ulcay , Semiha Akin Eroglu

Purpose

This two-centre, randomised controlled, pre-test–post-test design study aimed to evaluate the effect of Active Cycle of Breathing Techniques (ACBT) on dyspnoea, cough, and fatigue, which comprise the Respiratory Distress Symptom Cluster (RDSC) in patients with lung cancer.

Methods

The sample included 73 patients with non-small cell lung cancer (NSCLC) undergoing their first cycle of chemotherapy (36 intervention, 37 control). Data were collected using the Cancer Dyspnoea Scale (CDS), Leicester Cough Questionnaire (LCQ), and Hirai Cancer Fatigue Scale (HCFS). The intervention group received ACBT training and performed exercises twice daily with the support of a video. Follow-up calls were made weekly (days 7, 14, 21). Pre-test assessments were conducted on the first day of chemotherapy; post-tests were completed on day 28.

Results

Demographic and clinical characteristics did not differ significantly between the two groups. In the intervention group, significant improvements were observed in dyspnoea and fatigue, as indicated by decreased CDS and HCFS scores, and in cough-related quality of life, as reflected by increased LCQ scores (p = 0.000). Additionally, strong and significant correlations were found among the total and subscale scores of the CDS, LCQ, and HCFS within the intervention group (p = 0.000), supporting the pre.
sence of a RDSC.

Conclusions

ACBT demonstrated a positive impact on dyspnoea, cough, and fatigue in lung cancer patients. Integrating ACBT into routine nursing care is recommended to support the management of the RDSC in patients with lung cancer.
目的:这项双中心、随机对照、前-后-试验设计研究旨在评估主动呼吸循环技术(ACBT)对肺癌患者呼吸困难、咳嗽和疲劳的影响,这些症状包括呼吸窘迫症状群(RDSC)。方法:73例接受第一周期化疗的非小细胞肺癌(NSCLC)患者(干预组36例,对照组37例)。采用癌症呼吸困难量表(CDS)、莱斯特咳嗽问卷(LCQ)和平井癌症疲劳量表(HCFS)收集数据。干预组接受ACBT训练,并在视频的支持下每天进行两次练习。随访电话每周(第7、14、21天)。在化疗的第一天进行测试前评估;后测于第28天完成。结果:两组患者的人口学和临床特征无显著差异。在干预组中,呼吸困难和疲劳显著改善,CDS和HCFS评分下降,咳嗽相关生活质量显著改善,LCQ评分增加(p = 0.000)。此外,在干预组内,CDS、LCQ和HCFS的总得分和子量表得分之间存在强烈且显著的相关性(p = 0.000),支持了前。RDSC的含义。结论:ACBT对肺癌患者的呼吸困难、咳嗽和疲劳有积极的影响。建议将ACBT纳入常规护理,以支持肺癌患者RDSC的管理。
{"title":"Investigation of the effect of active cycle of breathing techniques on respiratory distress symptom cluster in patients with lung cancer: A randomised controlled trial","authors":"Doga Ulcay ,&nbsp;Semiha Akin Eroglu","doi":"10.1016/j.ejon.2025.103029","DOIUrl":"10.1016/j.ejon.2025.103029","url":null,"abstract":"<div><h3>Purpose</h3><div>This two-centre, randomised controlled, pre-test–post-test design study aimed to evaluate the effect of Active Cycle of Breathing Techniques (ACBT) on dyspnoea, cough, and fatigue, which comprise the Respiratory Distress Symptom Cluster (RDSC) in patients with lung cancer.</div></div><div><h3>Methods</h3><div>The sample included 73 patients with non-small cell lung cancer (NSCLC) undergoing their first cycle of chemotherapy (36 intervention, 37 control). Data were collected using the Cancer Dyspnoea Scale (CDS), Leicester Cough Questionnaire (LCQ), and Hirai Cancer Fatigue Scale (HCFS). The intervention group received ACBT training and performed exercises twice daily with the support of a video. Follow-up calls were made weekly (days 7, 14, 21). Pre-test assessments were conducted on the first day of chemotherapy; post-tests were completed on day 28.</div></div><div><h3>Results</h3><div>Demographic and clinical characteristics did not differ significantly between the two groups. In the intervention group, significant improvements were observed in dyspnoea and fatigue, as indicated by decreased CDS and HCFS scores, and in cough-related quality of life, as reflected by increased LCQ scores (p = 0.000). Additionally, strong and significant correlations were found among the total and subscale scores of the CDS, LCQ, and HCFS within the intervention group (p = 0.000), supporting the pre.</div><div>sence of a RDSC.</div></div><div><h3>Conclusions</h3><div>ACBT demonstrated a positive impact on dyspnoea, cough, and fatigue in lung cancer patients. Integrating ACBT into routine nursing care is recommended to support the management of the RDSC in patients with lung cancer.</div></div>","PeriodicalId":51048,"journal":{"name":"European Journal of Oncology Nursing","volume":"79 ","pages":"Article 103029"},"PeriodicalIF":2.7,"publicationDate":"2025-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145514874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-embolisation syndrome trajectories and predictors in patients with hepatocellular carcinoma undergoing transarterial chemoembolisation: A retrospective study 肝细胞癌经动脉化疗栓塞患者栓塞后综合征轨迹和预测因素:一项回顾性研究。
IF 2.7 3区 医学 Q1 NURSING Pub Date : 2025-10-31 DOI: 10.1016/j.ejon.2025.103031
Myoung Soo Kim

Purpose

Although post-embolisation syndrome (PES) is a well-known adverse effect, little is known about its trajectory across repeated transarterial chemoembolization (TACE) sessions. This study aimed to examine longitudinal changes in PES occurrence across repeated TACE sessions and to explore whether the predictors of PES vary depending on the treatment session.

Methods

This study comprised a retrospective review of 1491 records of TACE from a single tertiary hospital. Clinical data including tumour characteristics, procedural details, and laboratory parameters were extracted. Descriptive statistics, chi-square tests, analysis of variance (ANOVA) with Scheffé post-hoc tests, and Pearson correlations analyses were performed. A generalised linear mixed model with random intercepts was applied and sensitivity analyses were conducted to test the robustness of the model.

Results

PES occurrence remained stable up to the eighth session but showed greater variability and a resurgence in frequency after the 14th TACE. Elevated post-TACE alanine aminotransferase (ALT) levels were consistently associated with increased odds of PES across all treatment phases, with a five-fold higher risk observed after the 14th session (OR = 5.17, p = .27). Overall, liver enzyme and immune-inflammatory markers such as ALT and C-reactive protein (CRP)-to-lymphocyte ratio were the primary determinants influencing PES trajectory.

Conclusions

This study identified the longitudinal trajectory and predictors of PES across repeated TACE sessions, showing increased incidence after the 14th session and consistent associations with hepatic and immune-inflammatory markers. These findings highlight the need for phase-specific, nurse-led monitoring and hepatoprotective care to manage evolving PES risks throughout the TACE trajectory.
目的:虽然栓塞后综合征(PES)是一种众所周知的不良反应,但对其在重复经动脉化疗栓塞(TACE)期间的发展轨迹知之甚少。本研究旨在检查反复TACE治疗期间PES发生的纵向变化,并探讨PES的预测因素是否因治疗期而异。方法:回顾性分析某三级医院1491例TACE病例。临床资料包括肿瘤特征、手术细节和实验室参数。采用描述性统计、卡方检验、scheff事后检验方差分析(ANOVA)和Pearson相关分析。采用随机截距的广义线性混合模型,并进行敏感性分析以检验模型的鲁棒性。结果:PES的发生在第八次治疗前保持稳定,但在第14次TACE治疗后表现出更大的变异性和复发频率。在所有治疗阶段,tace后谷丙转氨酶(ALT)水平升高始终与PES的发生率增加相关,第14期后观察到的风险增加了5倍(OR = 5.17, p = 0.27)。总体而言,肝酶和免疫炎症标志物,如ALT和c反应蛋白(CRP)与淋巴细胞的比率是影响PES轨迹的主要决定因素。结论:本研究确定了重复TACE治疗期间PES的纵向轨迹和预测因素,显示第14次治疗后PES的发病率增加,并与肝脏和免疫炎症标志物保持一致。这些研究结果强调需要针对特定阶段,护士主导的监测和肝保护护理,以管理在整个TACE过程中不断变化的PES风险。
{"title":"Post-embolisation syndrome trajectories and predictors in patients with hepatocellular carcinoma undergoing transarterial chemoembolisation: A retrospective study","authors":"Myoung Soo Kim","doi":"10.1016/j.ejon.2025.103031","DOIUrl":"10.1016/j.ejon.2025.103031","url":null,"abstract":"<div><h3>Purpose</h3><div>Although post-embolisation syndrome (PES) is a well-known adverse effect, little is known about its trajectory across repeated transarterial chemoembolization (TACE) sessions. This study aimed to examine longitudinal changes in PES occurrence across repeated TACE sessions and to explore whether the predictors of PES vary depending on the treatment session.</div></div><div><h3>Methods</h3><div>This study comprised a retrospective review of 1491 records of TACE from a single tertiary hospital. Clinical data including tumour characteristics, procedural details, and laboratory parameters were extracted. Descriptive statistics, chi-square tests, analysis of variance (ANOVA) with Scheffé post-hoc tests, and Pearson correlations analyses were performed. A generalised linear mixed model with random intercepts was applied and sensitivity analyses were conducted to test the robustness of the model.</div></div><div><h3>Results</h3><div>PES occurrence remained stable up to the eighth session but showed greater variability and a resurgence in frequency after the 14th TACE. Elevated post-TACE alanine aminotransferase (ALT) levels were consistently associated with increased odds of PES across all treatment phases, with a five-fold higher risk observed after the 14th session (OR = 5.17, p = .27). Overall, liver enzyme and immune-inflammatory markers such as ALT and C-reactive protein (CRP)-to-lymphocyte ratio were the primary determinants influencing PES trajectory.</div></div><div><h3>Conclusions</h3><div>This study identified the longitudinal trajectory and predictors of PES across repeated TACE sessions, showing increased incidence after the 14th session and consistent associations with hepatic and immune-inflammatory markers. These findings highlight the need for phase-specific, nurse-led monitoring and hepatoprotective care to manage evolving PES risks throughout the TACE trajectory.</div></div>","PeriodicalId":51048,"journal":{"name":"European Journal of Oncology Nursing","volume":"79 ","pages":"Article 103031"},"PeriodicalIF":2.7,"publicationDate":"2025-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145551484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Family-based belief interventions to enhance resilience in breast cancer patients undergoing chemotherapy: A qualitative study 基于家庭的信念干预对乳腺癌化疗患者恢复力的增强:一项定性研究。
IF 2.7 3区 医学 Q1 NURSING Pub Date : 2025-10-30 DOI: 10.1016/j.ejon.2025.103025
Dwi Retnaningsih , Nursalam , Hanik Endang Nihayati , Ferry Efendi , Mira Triharini

Purpose

This study aimed to explore the mechanisms and perceived impact of faith-based family interventions on psychological resilience among breast cancer patients undergoing chemotherapy.

Methods

This study employed a qualitative methodology with a phenomenological design to investigate how relatives of patients with breast cancer have dealt with offering faith-based support throughout chemotherapy. Twenty family members of patients, purposefully chosen, participated in semi-structured interviews to gather the data. Field notes, an interview guide, and a demographic data questionnaire are among the study tools. Face-to-face interviews were conducted, videotaped with consent, and subjected to thematic analysis using NVivo software. Peer debriefing, member verification, triangulation, and audit trail recording all help preserve the authenticity of the data.

Results

In this study, 20 family members of patients with breast cancer receiving chemotherapy participated. Four major themes emerged from the data analysis: information requirements, family resilience, caregiving obstacles, and types of family support (emotional, informational, instrumental, esteem, and spiritual). These themes highlight the importance of families playing an active role in supporting patients with their treatment.

Conclusions

Interventions based on family beliefs are crucial for enhancing breast cancer patients' quality of life and resilience during chemotherapy. Integrating faith-based family support into oncology nursing practice is crucial for improving the quality of life and resilience of patients with breast cancer by including their families in their treatment.
目的:本研究旨在探讨基于信仰的家庭干预对乳腺癌化疗患者心理弹性的影响机制和感知效应。方法:本研究采用现象学设计的定性方法来调查乳腺癌患者的亲属如何在化疗期间提供基于信仰的支持。有目的地选择了20名患者的家庭成员,参与了半结构化访谈来收集数据。研究工具包括实地记录、访谈指南和人口统计数据问卷。进行面对面访谈,在征得同意的情况下进行录像,并使用NVivo软件进行专题分析。同行汇报、成员验证、三角测量和审计跟踪记录都有助于保持数据的真实性。结果:本研究共有20名接受化疗的乳腺癌患者家属参与。数据分析中出现了四个主要主题:信息需求、家庭弹性、照顾障碍和家庭支持类型(情感、信息、工具、尊重和精神)。这些主题强调了家庭在支持患者治疗方面发挥积极作用的重要性。结论:基于家庭信念的干预对提高乳腺癌患者化疗期间的生活质量和适应能力至关重要。将基于信仰的家庭支持纳入肿瘤护理实践对于提高乳腺癌患者的生活质量和恢复能力至关重要,因为乳腺癌患者的家庭可以参与治疗。
{"title":"Family-based belief interventions to enhance resilience in breast cancer patients undergoing chemotherapy: A qualitative study","authors":"Dwi Retnaningsih ,&nbsp;Nursalam ,&nbsp;Hanik Endang Nihayati ,&nbsp;Ferry Efendi ,&nbsp;Mira Triharini","doi":"10.1016/j.ejon.2025.103025","DOIUrl":"10.1016/j.ejon.2025.103025","url":null,"abstract":"<div><h3>Purpose</h3><div>This study aimed to explore the mechanisms and perceived impact of faith-based family interventions on psychological resilience among breast cancer patients undergoing chemotherapy.</div></div><div><h3>Methods</h3><div>This study employed a qualitative methodology with a phenomenological design to investigate how relatives of patients with breast cancer have dealt with offering faith-based support throughout chemotherapy. Twenty family members of patients, purposefully chosen, participated in semi-structured interviews to gather the data. Field notes, an interview guide, and a demographic data questionnaire are among the study tools. Face-to-face interviews were conducted, videotaped with consent, and subjected to thematic analysis using NVivo software. Peer debriefing, member verification, triangulation, and audit trail recording all help preserve the authenticity of the data.</div></div><div><h3>Results</h3><div>In this study, 20 family members of patients with breast cancer receiving chemotherapy participated. Four major themes emerged from the data analysis: information requirements, family resilience, caregiving obstacles, and types of family support (emotional, informational, instrumental, esteem, and spiritual). These themes highlight the importance of families playing an active role in supporting patients with their treatment.</div></div><div><h3>Conclusions</h3><div>Interventions based on family beliefs are crucial for enhancing breast cancer patients' quality of life and resilience during chemotherapy. Integrating faith-based family support into oncology nursing practice is crucial for improving the quality of life and resilience of patients with breast cancer by including their families in their treatment.</div></div>","PeriodicalId":51048,"journal":{"name":"European Journal of Oncology Nursing","volume":"79 ","pages":"Article 103025"},"PeriodicalIF":2.7,"publicationDate":"2025-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145524887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stratified linear regression analysis of factors associated with chemotherapy-induced taste alterations in gastrointestinal cancer patients: A cross-sectional study in China 中国胃肠癌患者化疗引起的味觉改变相关因素的分层线性回归分析:一项横断面研究
IF 2.7 3区 医学 Q1 NURSING Pub Date : 2025-10-28 DOI: 10.1016/j.ejon.2025.103027
Shi Yin , Dongjing Xie , Rongya Wang , Jiao Qian , Xiaofen Shi , Honghong Wang

Purpose

This study aimed to investigate the incidence, influencing factors, and clinical correlates of Chemotherapy-Induced Taste Alteration (CITA) in patients with gastrointestinal cancer.

Methods

A cross-sectional study was conducted involving 170 gastrointestinal cancer patients from a tertiary hospital in China. Participants completed the Chemotherapy-Induced Taste Alteration Scale (CITAS), the Index of Nausea, Vomiting, and Retching (INVR), and the Patient-Generated Subjective Global Assessment (PG-SGA). Data were analyzed using descriptive statistics, univariate analyses, correlation, and hierarchical regression to identify key predictors and interaction effects.

Results

The incidence of CITA was 74.7 %. The most prevalent issues were overall taste change (71.8 %) and feeding disturbance (45.9 %). Female gender, age <65, religious belief, plant alkaloid use, and higher chemotherapy cycles were significantly associated with worse CITA. Hierarchical regression revealed that retching (β = .80, p < .001) and nutritional status (β = .36, p < .001) were the strongest independent predictors, collectively explaining 47.0 % of the variance in CITAS scores. Interaction effects showed that the retching-CITA relationship was stronger in females but attenuated in patients receiving plant alkaloids.

Conclusions

CITA is highly prevalent in gastrointestinal cancer patients and is closely linked to retching and nutritional status. A stratified management approach is recommended, integrating standardized nutritional assessment with personalized antiemetic strategies, particularly for high-risk subgroups such as female patients. Future multicenter longitudinal studies are needed to elucidate causal pathways and optimize precision interventions for CITA.
目的:探讨胃肠道肿瘤患者化疗诱导味觉改变(CITA)的发生率、影响因素及临床相关因素。方法:对国内某三级医院170例胃肠癌患者进行横断面研究。参与者完成了化疗诱导味觉改变量表(CITAS)、恶心、呕吐和干呕指数(INVR)和患者主观整体评估(PG-SGA)。数据分析采用描述性统计、单变量分析、相关性和层次回归来确定关键预测因子和相互作用效应。结果:CITA的发生率为74.7%。最常见的问题是整体味觉变化(71.8%)和进食障碍(45.9%)。结论:CITA在胃肠道肿瘤患者中高发,且与干呕和营养状况密切相关。建议采用分层管理方法,将标准化营养评估与个性化止吐策略相结合,特别是对女性患者等高危亚群。未来的多中心纵向研究需要阐明因果途径和优化CITA的精确干预措施。
{"title":"Stratified linear regression analysis of factors associated with chemotherapy-induced taste alterations in gastrointestinal cancer patients: A cross-sectional study in China","authors":"Shi Yin ,&nbsp;Dongjing Xie ,&nbsp;Rongya Wang ,&nbsp;Jiao Qian ,&nbsp;Xiaofen Shi ,&nbsp;Honghong Wang","doi":"10.1016/j.ejon.2025.103027","DOIUrl":"10.1016/j.ejon.2025.103027","url":null,"abstract":"<div><h3>Purpose</h3><div>This study aimed to investigate the incidence, influencing factors, and clinical correlates of Chemotherapy-Induced Taste Alteration (CITA) in patients with gastrointestinal cancer.</div></div><div><h3>Methods</h3><div>A cross-sectional study was conducted involving 170 gastrointestinal cancer patients from a tertiary hospital in China. Participants completed the Chemotherapy-Induced Taste Alteration Scale (CITAS), the Index of Nausea, Vomiting, and Retching (INVR), and the Patient-Generated Subjective Global Assessment (PG-SGA). Data were analyzed using descriptive statistics, univariate analyses, correlation, and hierarchical regression to identify key predictors and interaction effects.</div></div><div><h3>Results</h3><div>The incidence of CITA was 74.7 %. The most prevalent issues were overall taste change (71.8 %) and feeding disturbance (45.9 %). Female gender, age &lt;65, religious belief, plant alkaloid use, and higher chemotherapy cycles were significantly associated with worse CITA. Hierarchical regression revealed that retching (β = .80, p &lt; .001) and nutritional status (β = .36, p &lt; .001) were the strongest independent predictors, collectively explaining 47.0 % of the variance in CITAS scores. Interaction effects showed that the retching-CITA relationship was stronger in females but attenuated in patients receiving plant alkaloids.</div></div><div><h3>Conclusions</h3><div>CITA is highly prevalent in gastrointestinal cancer patients and is closely linked to retching and nutritional status. A stratified management approach is recommended, integrating standardized nutritional assessment with personalized antiemetic strategies, particularly for high-risk subgroups such as female patients. Future multicenter longitudinal studies are needed to elucidate causal pathways and optimize precision interventions for CITA.</div></div>","PeriodicalId":51048,"journal":{"name":"European Journal of Oncology Nursing","volume":"79 ","pages":"Article 103027"},"PeriodicalIF":2.7,"publicationDate":"2025-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145508045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Experiences of exercise and its significance for the quality of life among patients with advanced cancer – A qualitative study 运动经历及其对晚期癌症患者生活质量的意义——一项定性研究
IF 2.7 3区 医学 Q1 NURSING Pub Date : 2025-10-28 DOI: 10.1016/j.ejon.2025.103028
Essi Nikkinen , Eeva Harju , Annastiina Hakulinen , Teemu J. Murtola , Jorma Sormunen , Elina Haavisto

Purpose

To explore the experiences of patients with advanced cancer regarding exercise and its significance for their quality of life.

Methods

A total of 17 patients participated in the study and were individually interviewed using semi-structured thematic interviews between April 2023 and April 2025. The interview data were subjected to inductive content analysis.

Results

Most patients with advanced cancer exercised several times weekly, for several hours each week. Patients engaged actively in aerobic activities, but the number of muscle-strengthening activities and stretching was limited. Following the onset of advanced cancer, patients’ ability to exercise declined, while their perceived importance of exercise increased. According to the experiences of patients with advanced cancer, exercise facilitated the preservation of health and contributed to the preservation of overall well-being.

Conclusion

At the onset of advanced cancer, healthcare professionals should discuss patients’ exercise habits and ensure that both the quantity and type of exercise are appropriate. If necessary, patients should be offered informational and practical support for implementing healthier exercise habits. Moreover, based on the experiences of patients with advanced cancer, exercise is perceived to have exclusively beneficial consequences for quality of life.
目的探讨晚期癌症患者的运动体验及其对生活质量的影响。方法于2023年4月至2025年4月对17例患者进行半结构化专题访谈。对访谈数据进行归纳内容分析。结果大多数晚期癌症患者每周锻炼几次,每周锻炼几个小时。患者积极进行有氧运动,但肌肉强化活动和拉伸的次数有限。随着晚期癌症的发作,患者的运动能力下降,而他们认为运动的重要性增加。根据晚期癌症患者的经验,运动有助于保持健康,并有助于保持整体健康。结论在晚期癌症发病时,医护人员应探讨患者的运动习惯,确保运动的量和类型都是合适的。如有必要,应向患者提供实施更健康运动习惯的信息和实际支持。此外,根据晚期癌症患者的经验,运动被认为对生活质量有完全有益的影响。
{"title":"Experiences of exercise and its significance for the quality of life among patients with advanced cancer – A qualitative study","authors":"Essi Nikkinen ,&nbsp;Eeva Harju ,&nbsp;Annastiina Hakulinen ,&nbsp;Teemu J. Murtola ,&nbsp;Jorma Sormunen ,&nbsp;Elina Haavisto","doi":"10.1016/j.ejon.2025.103028","DOIUrl":"10.1016/j.ejon.2025.103028","url":null,"abstract":"<div><h3>Purpose</h3><div>To explore the experiences of patients with advanced cancer regarding exercise and its significance for their quality of life.</div></div><div><h3>Methods</h3><div>A total of 17 patients participated in the study and were individually interviewed using semi-structured thematic interviews between April 2023 and April 2025. The interview data were subjected to inductive content analysis.</div></div><div><h3>Results</h3><div>Most patients with advanced cancer exercised several times weekly, for several hours each week. Patients engaged actively in aerobic activities, but the number of muscle-strengthening activities and stretching was limited. Following the onset of advanced cancer, patients’ ability to exercise declined, while their perceived importance of exercise increased. According to the experiences of patients with advanced cancer, exercise facilitated the preservation of health and contributed to the preservation of overall well-being.</div></div><div><h3>Conclusion</h3><div>At the onset of advanced cancer, healthcare professionals should discuss patients’ exercise habits and ensure that both the quantity and type of exercise are appropriate. If necessary, patients should be offered informational and practical support for implementing healthier exercise habits. Moreover, based on the experiences of patients with advanced cancer, exercise is perceived to have exclusively beneficial consequences for quality of life.</div></div>","PeriodicalId":51048,"journal":{"name":"European Journal of Oncology Nursing","volume":"79 ","pages":"Article 103028"},"PeriodicalIF":2.7,"publicationDate":"2025-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145528820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Breast cancer in the cycle of hope and hopelesness: A qualitative research 希望与绝望循环中的乳腺癌:一项定性研究。
IF 2.7 3区 医学 Q1 NURSING Pub Date : 2025-10-27 DOI: 10.1016/j.ejon.2025.103024
Behice Belkıs Çalışkan , Figen Şengün İnan , Reyhan Doğan , Yasemin Nazlı

Purpose

Hope is a crucial psychological resource that influences adaptation and coping during the cancer journey. This study aimed to explore the lived experiences of hope and hopelessness among breast cancer survivors.

Methods

A descriptive qualitative design was employed. Semi-structured, in-depth interviews were conducted with 19 women who had completed their hospital-based treatment for breast cancer within the past 3–5 years. Data were collected via Zoom and analyzed using inductive content analysis. The study was reported by the COREQ checklist.

Results

Four main themes emerged from the data: (1) The cycle of hope (fluctuations across diagnosis, treatment, and post-treatment); (2) Sources of hope (acceptance, positive appraisal of treatment, social and professional support); (3) Factors threatening hope (association with death, symptom burden, stigma, emotional isolation, caregiving responsibilities, and lack of professional support); and (4) Strategies to sustain hope (faith, remaining connected to life, cognitive reframing, treatment adherence, and redefining suffering as a shared human experience). Participants described hope as a shifting and vital internal force that helped them navigate uncertainty, while hopelessness was triggered by a lack of control, negative bodily changes, and unsupportive interactions with healthcare professionals.

Conclusion

Hope and hopelessness coexist as dynamic and fluctuating experiences in breast cancer survivors. These emotional responses are shaped by personal meaning-making, social context, and the quality of care interactions. Nurses should assess hope-related risks and offer targeted interventions. Hope-focused communication, emotional acknowledgment, and tailored psychosocial support can reduce hopelessness and improve survivors’ well-being.
目的:希望是一种重要的心理资源,影响着癌症旅程中的适应和应对。本研究旨在探讨乳腺癌幸存者的希望和绝望的生活经历。方法:采用描述性定性设计。对19名在过去3-5年内完成乳腺癌医院治疗的妇女进行了半结构化的深入访谈。通过Zoom收集数据,采用归纳内容分析法进行分析。该研究通过COREQ检查表进行报告。结果:从数据中出现了四个主要主题:(1)希望的周期(诊断、治疗和治疗后的波动);(2)希望的来源(接受、对治疗的积极评价、社会和专业支持);(3)威胁希望的因素(与死亡相关、症状负担、病耻感、情感孤立、照顾责任和缺乏专业支持);(4)维持希望的策略(信念、与生活保持联系、认知重构、坚持治疗、将痛苦重新定义为人类共同的经历)。参与者将希望描述为一种变化和重要的内在力量,帮助他们驾驭不确定性,而绝望是由缺乏控制、消极的身体变化以及与医疗保健专业人员的不支持互动引发的。结论:希望和绝望共存,是乳腺癌幸存者动态和波动的经历。这些情绪反应受到个人意义创造、社会环境和护理互动质量的影响。护士应该评估与希望相关的风险,并提供有针对性的干预措施。以希望为中心的沟通、情感上的认可和量身定制的社会心理支持可以减少绝望,改善幸存者的福祉。
{"title":"Breast cancer in the cycle of hope and hopelesness: A qualitative research","authors":"Behice Belkıs Çalışkan ,&nbsp;Figen Şengün İnan ,&nbsp;Reyhan Doğan ,&nbsp;Yasemin Nazlı","doi":"10.1016/j.ejon.2025.103024","DOIUrl":"10.1016/j.ejon.2025.103024","url":null,"abstract":"<div><h3>Purpose</h3><div>Hope is a crucial psychological resource that influences adaptation and coping during the cancer journey. This study aimed to explore the lived experiences of hope and hopelessness among breast cancer survivors.</div></div><div><h3>Methods</h3><div>A descriptive qualitative design was employed. Semi-structured, in-depth interviews were conducted with 19 women who had completed their hospital-based treatment for breast cancer within the past 3–5 years. Data were collected via Zoom and analyzed using inductive content analysis. The study was reported by the COREQ checklist.</div></div><div><h3>Results</h3><div>Four main themes emerged from the data: (1) The cycle of hope (fluctuations across diagnosis, treatment, and post-treatment); (2) Sources of hope (acceptance, positive appraisal of treatment, social and professional support); (3) Factors threatening hope (association with death, symptom burden, stigma, emotional isolation, caregiving responsibilities, and lack of professional support); and (4) Strategies to sustain hope (faith, remaining connected to life, cognitive reframing, treatment adherence, and redefining suffering as a shared human experience). Participants described hope as a shifting and vital internal force that helped them navigate uncertainty, while hopelessness was triggered by a lack of control, negative bodily changes, and unsupportive interactions with healthcare professionals.</div></div><div><h3>Conclusion</h3><div>Hope and hopelessness coexist as dynamic and fluctuating experiences in breast cancer survivors. These emotional responses are shaped by personal meaning-making, social context, and the quality of care interactions. Nurses should assess hope-related risks and offer targeted interventions. Hope-focused communication, emotional acknowledgment, and tailored psychosocial support can reduce hopelessness and improve survivors’ well-being.</div></div>","PeriodicalId":51048,"journal":{"name":"European Journal of Oncology Nursing","volume":"79 ","pages":"Article 103024"},"PeriodicalIF":2.7,"publicationDate":"2025-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145535018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European Journal of Oncology Nursing
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1